diabetes

AstraZeneca on expanding its diabetes research franchise
AstraZeneca on expanding its diabetes research franchise
Pharmaforum
AstraZeneca
diabetes
Flag link:
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Biocon
insulin
diabetes
Lantus
Mylan
drug manufacturing
Flag link:
Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns
Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns
Fierce Pharma
Eli Lilly
drug ads
COVID-19
diabetes
Flag link:
Preventing Type 1 diabetes by deleting a stress response gene
Preventing Type 1 diabetes by deleting a stress response gene
Fierce Biotech
type 1 diabetes
diabetes
beta cells
Flag link:
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
type 1 diabetes
diabetes
empagliflozin
Flag link:
US govt aims at high insulin prices with plan for $35 copay in Medicare
US govt aims at high insulin prices with plan for $35 copay in Medicare
Yahoo/Reuters
Donald Trump
insulin
drug pricing
Medicare
diabetes
Flag link:
Intarcia's speed bump at the FDA turns into a roadblock, as regulators once again turn thumbs down on diabetes drug/device
Intarcia's speed bump at the FDA turns into a roadblock, as regulators once again turn thumbs down on diabetes drug/device
Endpoints
Intarcia
FDA
ITCA 650
diabetes
devices
drug-device combos
Flag link:
Eli Lilly says its drug supply, including insulins, are safe from COVID-19 for now
Eli Lilly says its drug supply, including insulins, are safe from COVID-19 for now
Fierce Pharma
Eli Lilly
diabetes
insulin
drug shortages
COVID-19
Flag link:
Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug
Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug
Bloomberg
diabetes
metformin
NDMA
carcinogens
Flag link:
Companion Medical wins FDA nod for InPen diabetes management system
Companion Medical wins FDA nod for InPen diabetes management system
Drug Delivery Business News
Companion Medical
FDA
InPen
diabetes
insulin
Flag link:
Collaborative diabetes tech on the Horizon
Collaborative diabetes tech on the Horizon
EP Vantage
devices
diabetes
Abbott Labs
DexCom
Insulet
Omnipod Horizon
Flag link:
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Flag link:
VTV celebrates a double positive
VTV celebrates a double positive
EP Vantage
vTv Therapeutics
Alzheimer's disease
diabetes
azeliragon
clinical trials
Flag link:
Lilly, Novo Nordisk Fight Insulin Biosimilars With Tweaks to FDA Draft Guidance
Lilly, Novo Nordisk Fight Insulin Biosimilars With Tweaks to FDA Draft Guidance
RAPS.org
diabetes
insulin
biosimilars
Eli Lilly
Novo Nordisk
FDA
competition
Flag link:
Zealand acquires a struggling diabetes med-tech in push into US market
Zealand acquires a struggling diabetes med-tech in push into US market
Endpoints
Zealand Pharma
M&A
Valeritas
devices
diabetes
Flag link:
Why Diabetes Stock Insulet Jumped 13.3% in January -- After Soaring 116% in 2019
Why Diabetes Stock Insulet Jumped 13.3% in January -- After Soaring 116% in 2019
Motley Fool
Insulet
diabetes
tubeless insulin pumps
insulin pumps
devices
Flag link:
Novo Nordisk investing $117.4M in manufacturing site in Denmark
Novo Nordisk investing $117.4M in manufacturing site in Denmark
Fierce Pharma
Novo Nordisk
insulin
diabetes
drug manufacturing
Flag link:
Smart Insulin Patch Could Revolutionize Diabetes Treatments
Smart Insulin Patch Could Revolutionize Diabetes Treatments
BioSpace
insulin patch
diabetes
insulin
Flag link:
Ozempic acceleration buoys Novo Nordisk, and threatens Lilly
Ozempic acceleration buoys Novo Nordisk, and threatens Lilly
Pharmaforum
Novo Nordisk
earnings
Ozempic
Eli Lilly
diabetes
Flag link:
Tirzepatide’s time to shine for Lilly
Tirzepatide’s time to shine for Lilly
EP Vantage
Eli Lilly
tirzepatide
diabetes
Flag link:

Pages